Protecting health workers from nosocomial Hepatitis B infections: A review of strategies and challenges for implementation of Hepatitis B vaccination among health workers in Sub-Saharan Africa

被引:32
作者
Malewezi B. [1 ]
Omer S.B. [1 ,2 ,3 ]
Mwagomba B. [4 ]
Araru T. [4 ]
机构
[1] Hubert Department of Global Health, Emory University Rollins School of Public Health, Atlanta, GA
[2] Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA
[3] Emory Vaccine Center, Atlanta, GA
[4] Ministry of Health, Capital City
关键词
Africa; Health worker; Hepatitis B; Hepatitis B vaccine;
D O I
10.1016/j.jegh.2016.04.003
中图分类号
学科分类号
摘要
The Sub-Saharan region has the highest Hepatitis B virus (HBV) rates, and health workers are at an increased risk of contracting nosocomial HBV infection. Vaccination of health workers plays a critical role in protecting them from sequelae of HBV; however, health-worker vaccination remains a challenge for many countries. This study was conducted to review practices/measures and challenges in the Sub-Saharan region relating to vaccination of health workers against HBV. We performed a literature review of articles addressing any aspect of HBV vaccination of health workers in the Sub-Saharan region sourced from PubMed, Embase, and Web of Science, including a case study of Malawi policies and strategies in training institutions and facilities. Our findings indicated that HBV awareness and vaccination were relatively high, but vaccination rates were lower, with 4.6–64.4% of those “ever vaccinated” completing the vaccination regimen. There was also great variation in the proportion of health workers exhibiting natural immunity from previous exposure (positive for anti-Hepatitis B core antibodies; 41–92%). Commonly cited reasons for non-uptake of vaccine included cost, lack of awareness of vaccine availability, and inadequate information concerning the vaccine. Countries in this region will require locally relevant data to develop cost-effective strategies that maximize the benefit to their health workers due to the great diversity of HBV epidemiology in the region. © 2016 Ministry of Health, Saudi Arabia
引用
收藏
页码:229 / 241
页数:12
相关论文
共 62 条
  • [1] Erhabor O., Ejele O.A., Nwauche C.A., Epidemiology and management of occupational exposure to blood borne viral infections in a resource poor setting: the case for availability of post exposure prophylaxis, Niger J Clin Pract, 10, 2, pp. 100-104, (2007)
  • [2] WHO, W.H.O., Global policy report on the prevention and control of viral hepatitis in WHO Member States, (2013)
  • [3] Alqahtani J.M., Abu-Eshy S.A., Mahfouz A.A., El-Mekki A.A., Asaad A.M., Seroprevalence of hepatitis B and C virus infections among health students and health care workers in the Najran region, southwestern Saudi Arabia: the need for national guidelines for health students, BMC Public Health, 14, (2014)
  • [4] Ciorlia L.A., Zanetta D.M., Hepatitis B in healthcare workers: prevalence, vaccination and relation to occupational factors, Braz J Infect Dis, 9, 5, pp. 384-389, (2005)
  • [5] Fritzsche C., Becker F., Hemmer C.J., Riebold D., Klammt S., Hufert F., Et al., Hepatitis B and C: neglected diseases among health care workers in Cameroon, Trans R Soc Trop Med Hyg, 107, 3, pp. 158-164, (2013)
  • [6] Fortunato F., Tafuri S., Cozza V., Martinelli D., Prato R., Low vaccination coverage among italian healthcare workers in 2013: contributing to the voluntary vs. mandatory vaccination debate, Hum Vaccin Immunother, 11, 1, (2014)
  • [7] Noah D.N., Ngaba G.P., Bagnaka S.F., Assi C., Ngantchet E., Njoya O., Evaluation of vaccination status against hepatitis B and HBsAg carriage among medical and paramedical staff of the Yaounde Central Hospital, Cameroon, Pan Afr Med J, 16, (2013)
  • [8] Askarian M., Yadollahi M., Kuochak F., Danaei M., Vakili V., Momeni M., Precautions for health care workers to avoid hepatitis B and C virus infection, Int J Occup Environ Med, 2, 4, pp. 191-198, (2011)
  • [9] Ott J.J., Stevens G.A., Groeger J., Wiersma S.T., Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity, Vaccine, 30, 12, pp. 2212-2219, (2012)
  • [10] Andre F., Hepatitis B epidemiology in Asia, the Middle East and Africa, Vaccine, 18, pp. S20-S22, (2000)